Organon (OGN) Research & Development (2020 - 2026)

Organon has reported Research & Development for 7 years, with the latest figure at $90.0 million in Q2 2026.

• On a quarterly basis, Research & Development fell 5.26% year-over-year to $90.0 million in Q2 2026; TTM through Jun 2026 was $358.0 million, a 17.13% decrease from a year earlier, with the FY2025 full-year figure at $366.0 million, down 21.96% from the prior year.
• Research & Development was $90.0 million for Q2 2026 at Organon, down from $93.0 million in the prior quarter.
• The five-year high for Research & Development was $142.0 million in Q4 2022, with the low at $84.0 million in Q3 2025.
• Average Research & Development over 5 years is $112.1 million, with a median of $111.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Research & Development surged 47.67% in 2022, then slumped 30.0% in 2025.
• Over 5 years, Research & Development stood at $142.0 million in 2022, then declined by 5.63% to $134.0 million in 2023, then fell by 2.99% to $130.0 million in 2024, then decreased by 30.0% to $91.0 million in 2025, then decreased by 1.1% to $90.0 million in 2026.
• The last three Research & Development figures came in at $90.0 million (Q2 2026), $93.0 million (Q1 2026), and $91.0 million (Q4 2025), per Business Quant data.